Patents Assigned to Verex Pharmaceuticals (Europe) Limited
  • Deuterated CFTR potentiators
    Patent number: 10479766
    Abstract: This invention relates to compounds of Formula I: and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a CFTR potentiator.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: November 19, 2019
    Assignee: Verex Pharmaceuticals (Europe) Limited
    Inventor: Adam J. Morgan